The European Bank for Reconstruction and Development (EBRD) has provided JSC Farmak (Kyiv) with a loan of EUR 20 million to replenish working capital, according to a press release from the EBRD.
"The EBRD is lending EUR 20 million to a leading Ukrainian pharmaceuticals manufacturer, JSC Farmak, under its EUR 2 billion Resilience and Livelihoods Framework supporting countries affected by the war in Ukraine," the report says.
The program provides for the sustainability and preservation of livelihoods and support for countries affected by the war in Ukraine.
According to the EBRD, the total amount of the Program is EUR 2 billion.
The EBRD reports that this loan has a 5.5% first loss guarantee under the EBRD's Shareholder Special Fund Risk Sharing Programme. Thus, the total donor guarantee will cover 50% of the loan amount.
Advertising
Advertising
MORE ABOUT
EBRD provides Credit Agricole Bank EUR 150 mln guarantee for business lending
09:57, 03.12.2025
EBRD to provide Ukrhydroenergo EUR 75 mln, expects additional EUR 20 mln in investment grants
20:34, 02.12.2025
EBRD provides guarantee for Ukrsibbank loan to develop EVA logistics hubs
13:36, 26.11.2025
Ukrainian pharma manufacturers lose 3-5% of revenues due to state regulation – expert
11:10, 18.11.2025
IFC and EBRD co-invest $25 mln in Dragon Capital's Rebuild Ukraine Fund
11:55, 14.11.2025
LATEST
2026 state budget, once war continues, to require at least UAH 325 bln – Pidlasa
20:32, 22.12.2025
Ukraine unveils first cheese map and printed guide for 2021-2025
20:31, 22.12.2025
New bus market in Ukraine will grow by 13-15% by 2025 – expert
19:57, 22.12.2025
Ukraine's real GDP growth accelerates to 3.6% in Nov due to later corn harvest – IER
16:52, 22.12.2025
Gen.Hope center for child recovery finds first $7 mln from Canadian, UK donors